Current anti-cancer drugs, including paclitaxel, doxorubicin, epirubicin, lapatinib, gefitibin, imatinib and cisplatin, have been confirmed to mediating their cytotoxic and cytostatic functions through FOXO3 and FOXM1. Here, FOXM1 is linked to cancer.